
Sign up to save your podcasts
Or


Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
By American Academy of Neurology4.8
129129 ratings
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis.
Show reference:
https://www.nejm.org/doi/full/10.1056/NEJMoa2501561

497 Listeners

296 Listeners

52 Listeners

288 Listeners

3,342 Listeners

258 Listeners

13 Listeners

21 Listeners

194 Listeners

513 Listeners

365 Listeners

6,352 Listeners

180 Listeners

370 Listeners

79 Listeners